drugset / Trial / NCT00082069

Invaplex 50 Vaccine Dose-Ranging

NCT00082069 ↗

Non-randomizedSingle-groupOpen-labelPrevention

Summary

The vaccine is given as a nose spray. Volunteers will receive a 3-dose vaccination with doses spaced two weeks apart. Volunteers will be assigned to a vaccination group based on their order of enrollment with consideration of their availability to complete the necessary vaccinations and follow-up visits.

Timeline

Start
2004-04
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Invaplex 50 Vaccine 10 ug Intranasal
Subject Invaplex 50 Vaccine 50 ug Intranasal
Subject Invaplex 50 Vaccine 240 ug Intranasal
Subject Invaplex 50 Vaccine 480 ug Intranasal

Indications